The Korean NHIS only covers DAPT combinations of aspirin and additional antiplatelet agents, such as clopidogrel, ticlopidine, prasugrel, ticagrelor, triflusal, or cilostazol. Therefore, patients receiving DAPT were defined as those treated with aspirin combined with another antiplatelet agent. Dual ...
Previous studies have suggested a benefit of cilostazol in addition to standard dual-antiplatelet therapy (DAPT), reducing in-stent late luminal loss and r... MF Zuliani Mauro,JA Mangione,CJ Jr,... - 《Journal of Invasive Cardiology》 被引量: 1发表: 2017年 e0343 Triple versus dual antiplat...
Xue Y,Feng ZW,Li XY,et al.The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation:a combined clinical study and computational system pharmacology analysis[J].Acta Pharmacol Sin,2018,39(2):205-212. Google ...
We planned to randomly assign 2,110 patients treated with second-generation DES to triple (aspirin, clopidogrel, and cilostazol) and dual (aspirin, clopidogrel, and placebo) antiplatelet therapy groups. The primary end point was a composite of death, myocardial infarction, ischemic stroke, or ...
Although a reduction in platelet reactivity and improved clinical outcomes occur when using adjunctive cilostazol with dual antiplatelet therapy, this can lead to an increased risk of hemorrhagic complications. Therefore, our current study examined patients undergoing CAS and evaluated the impact of ...
Objective We previously reported that the antiplatelet action is intensified with combined use of clopidogrel and cilostazol in ischemic stroke patients using the VerifyNow P2Y12 Assay. In this study, the relationship between the cilostazol dose and the platelet function achieved with combination therapy ...
Although a reduction in platelet reactivity and improved clinical outcomes occur when using adjunctive cilostazol with dual antiplatelet therapy, this can lead to an increased risk of hemorrhagic complications. Therefore, our current study examined patients undergoing CAS and evaluated the impact of ...
Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke. Intern Med 2013;52:1043-7Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke. Maruyama H,Fukuoka T,...
CilostazolPoint-of-caresystemsBackground Both new dual antiplatelet therapy (DAT; aspirin and prasugrel) and triple antiplatelet therapy (TAT; aspirin, clopidogrel and cilostazol) are more potent than classic \\{DAT\\} (aspirin and clopidogrel). We compared the antiplatelet efficacy between new \\...
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI[J] . Tae-Hyun Yang,Han-Young Jin,Kyu-Nam Choi,Ungjeong Do,Hyung Jun Kim,...